Compare Hormel Foods Corp (HRL) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hormel Foods Corp vs Johnson & Johnson — how do they compare? Hormel Foods Corp trades at $25.19 (market cap $13.91B), while Johnson & Johnson trades at $250.82 (market cap $598.96B). The key difference: Johnson & Johnson is far larger — about 43.1× Hormel Foods Corp's market cap, and Hormel Foods Corp pays the higher dividend (4.63%). Which is the better fit depends on your goals.
| HRL | JNJ | |
|---|---|---|
Market Cap | $13.91B | $598.96B |
Sector | Consumer Staples | Health |
52-Week High | $29.52 | $267.24 |
52-Week Low | $19.74 | $164.36 |
Enterprise Value | $15.91B | $631.90B |
Dividend Yield | 4.63% | 2.15% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hormel Foods (HRL) trades at $25.115, down 1.1% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported revenue of $12.11B in 2025 with a net income margin of 3.82%, and has beaten EPS estimates for three consecutive quarters. Recent news highlights its status as a Dividend King with 60 consecutive years of dividend increases, and the sale of its Ceratti business in Brazil aims to streamline international operations.
Outlook remains cautious with modest growth projections; the stock offers a reliable dividend but faces margin pressures and competitive headwinds. Analyst consensus is mixed with a $26.33 price target, suggesting limited upside. Key risks include earnings volatility and macroeconomic impacts on consumer staples demand.
Johnson & Johnson (JNJ) trades at $250.61, down 0.96% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $2.90 versus $2.84 expected, and revenue growth of 6.6% year-over-year. The stock shows robust profitability with a net income margin of 21.48% and ROE of 26.42%, supported by consistent dividend payments including the recent $1.34 per share declared for H1-2026.
JNJ presents a favorable investment case with analyst consensus price target of $279.33 implying ~11% upside, though rising debt-to-asset ratio to 24.06% in 2025 and volatile cash flow trends pose risks. The healthcare giant's diversified portfolio and raised full-year guidance underpin long-term stability, but investors should monitor execution amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
